NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3027% below fair value
$11.83+0.11 (+0.94%)
Close on Nov 13, 2026Market cap $1.38BP/E –Yield –
NovoCure statistics
88 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 3.94
- 4.81
Enterprise valuationIndustry
- EV / Sales
- 1.81
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 3.84%
- 3.32%
- Shares Change (QoQ)
- 0.41%
- 0.20%
- Float
- 113M
- 37M
- Shares Held by Insiders
- 3.01%
- 10.5%
- Shares Held by Institutions
- 88.5%
- 60.5%
Short sellingIndustry
- Short Interest
- 13M
- –
- Short Interest Change
- 0.71%
- -2.57%
- Short % of Float
- 11.4%
- 5.11%
- Short % of Shares Outstanding
- 11.0%
- 3.98%
- Days to Cover
- 6.02
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $21.45
- –
- 52-Week Low
- $9.82
- –
- 20-Day Moving Average
- $13.67
- –
- 50-Day Moving Average
- $14.84
- –
- 200-Day Moving Average
- $14.79
- –
- Average True Range (14)
- $0.81
- –
- Price Change (1 Week)
- -10.9%
- 0.99%
- Price Change (1 Month)
- -17.9%
- -3.52%
- Price Change (3 Months)
- -32.5%
- -7.86%
- Price Change (6 Months)
- -32.7%
- -1.12%
- Price Change (YTD)
- -8.51%
- -2.92%
- Price Change (1 Year)
- 4.14%
- -1.37%
- Price Change (3 Years)
- -7.58%
- 3.24%
- Price Change (5 Years)
- -89.7%
- -50.4%
- Price Change (10 Years)
- 31.4%
- 58.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.68
- 0.76
- Relative Strength Index (14)
- 33.6
- 46.7
- Volatility (1 Year)
- 80.8%
- 64.2%
- Beta (5 Years)
- 1.56
- 1.04
MarginsIndustry
- Pretax Margin
- -18.0%
- -2.32%
- EBITDA Margin
- -14.8%
- -2.52%
- FCF Margin
- -3.39%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- -35.2%
- -17.3%
- Return on Assets (ROA)
- -11.1%
- -12.3%
- Return on Invested Capital (ROIC)
- -70.8%
- -2.83%
- Return on Capital Employed (ROCE)
- -22.3%
- -8.13%
Financial positionIndustry
- Current Ratio
- 2.49
- 2.49
- Quick Ratio
- 0.76
- 1.53
- Debt / Equity
- 0.07
- 0.42
GrowthIndustry
- Revenue Growth (YoY)
- 12.9%
- 9.42%
- Revenue Growth (3Y CAGR)
- 6.81%
- 7.08%
- Revenue Growth (5Y CAGR)
- 5.80%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.66
- 0.59
- Inventory Turnover
- 4.18
- 2.20
- Revenue Per Employee
- $451.96K
- $331.99K
- Profits Per Employee
- -$75.84K
- -$46.47K
- Employee Count
- 1,605
- 193
- WACC
- 12.8%
- 9.91%
Income statement (TTM)Industry
- Pretax Income
- -$130.54M
- -$1.83M
Balance sheetIndustry
- Net Cash (Debt)
- $71.73M
- $3.95M
- Net Cash Per Share
- $0.61
- $0.26
- Equity (Book Value)
- $350.61M
- $63.80M
- Book Value Per Share
- $3.00
- $3.26
- Tangible Book Value
- $350.61M
- $11.61M
- Working Capital
- $402.86M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$23.89M
- -$3.94M
- FCF Per Share
- -$0.21
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -8.80%
- -4.76%
- FCF Yield
- -1.78%
- 0.28%
- Buyback Yield
- -0.26%
- 0.80%
- Shareholder Yield
- -0.26%
- 1.12%
Taxes and interestIndustry
- Income Tax
- -$8.81M
- $1.55M
Scores and fair valueIndustry
- Altman Z-Score
- 0.35
- 2.47
- Piotroski F-Score
- 4
- 5
- Beneish M-Score
- -2.24
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NVCR | S&P 500 | Difference | NVCR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.3% | -3.0% | −14.2 pts | ||
| 3 months | -31.9% | -2.8% | −29.2 pts | ||
| Year to date | -8.5% | +11.5% | −20.0 pts | ||
| 1 year | +4.0% | +13.5% | −9.5 pts | ||
| 3 years | +4.0% | +77.7% | −73.7 pts | +1.3% | +21.1% |
| 5 years | -89.7% | +72.6% | −162.3 pts | -36.6% | +11.5% |
| 10 years | +32.2% | +308.2% | −276.0 pts | +2.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
13M NVCR shares were sold short on Oct 30, 2026, up 0.7% from the previous report, or 11.39% of the shares available to trade. At recent volumes it would take 6.0 days to buy them back. Over the last 20 sessions, 51.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 12,913,904 | +0.7% | 2,143,497 | 6.0 |
| Oct 15, 2026 | 12,823,054 | +14.9% | 1,663,731 | 7.7 |
| Sep 30, 2026 | 11,163,094 | -5.4% | 1,110,466 | 10.1 |
| Sep 15, 2026 | 11,796,425 | +9.3% | 1,027,830 | 11.5 |
| Aug 31, 2026 | 10,788,851 | +17.7% | 1,414,077 | 7.6 |
| Aug 14, 2026 | 9,170,033 | -9.5% | 1,096,067 | 8.4 |
| Jul 31, 2026 | 10,137,546 | -11.5% | 2,072,352 | 4.9 |
| Jul 15, 2026 | 11,460,044 | -3.6% | 1,530,548 | 7.5 |
| Jun 30, 2026 | 11,884,203 | +23.1% | 1,924,097 | 6.2 |
| Jun 15, 2026 | 9,650,837 | +5.4% | 1,615,169 | 6.0 |
| May 29, 2026 | 9,153,119 | +7.2% | 1,323,014 | 6.9 |
| May 15, 2026 | 8,541,120 | +22.6% | 1,993,657 | 4.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?